Comparison of Two-Year Outcome of Photodynamic Therapy in Combination with Intravitreal Aflibercept or Ranibizumab for Polypoidal Choroidal Vasculopathy

Comparison of Two-Year Outcome of Photodynamic Therapy in Combination with Intravitreal Aflibercept or Ranibizumab for Polypoidal Choroidal Vasculopathy

<i>Purpose:</i> To compare the two-year visual and anatomical outcomes of combination therapy of photodynamic therapy (PDT) with intravitreal aflibercept (IVA) or intravitreal ranibizumab (IVR) for patients with polypoidal choroidal vasculopathy (PCV), and to investigate the clinical fac...

Full description

Bibliographic Details
Main Authors: Hsin-Yu Weng, Tzu-Lun Huang, Pei-Yao Chang, Wei-Ting Ho, Yung-Ray Hsu, Fang-Ting Chen, Yun-Ju Chen, Jia-Kang Wang
Format: Article
Language:English
Published: MDPI AG 2021-01-01
Series:Applied Sciences
Subjects:
intravitreal injection
aflibercept
ranibizumab
photodynamic therapy
polypoidal choroidal vasculopathy
Online Access:https://www.mdpi.com/2076-3417/11/3/1194

Internet

https://www.mdpi.com/2076-3417/11/3/1194

Similar Items